MedPath

EDP-494

Generic Name
EDP-494

EDP-494-001: A Study of EDP-494 in Healthy Subjects and Hepatitis C Patients

Phase 1
Completed
Conditions
Hepatitis C
Interventions
Drug: Placebo
First Posted Date
2016-01-11
Last Posted Date
2017-01-23
Lead Sponsor
Enanta Pharmaceuticals, Inc
Target Recruit Count
100
Registration Number
NCT02652377
Locations
🇳🇿

Auckland Clinical Studies Ltd, Auckland, New Zealand

© Copyright 2025. All Rights Reserved by MedPath